Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Frontiers in Oncology|January 3, 2025
Biomarkers for immunotherapy resistance in non-small cell lung cancerCatriona Rother, Tom John, Annie WongExpert Review of Anticancer Therapy|September 27, 2016
Immunotherapy for malignant mesothelioma: reality checkBibhusal Thapa, D Neil Watkins, Tom JohnBiomedical Microdevices|March 9, 2013
Microfluidic based immunosensor for detection and purification of carbonylated proteinsHui Xia, Bobby Mathew, Tom John, et al.Cureus|December 18, 2024
Cortical Hand Knob Stroke: A Case Report of Isolated Hand Weakness and RecoverySharafath Hussain Zahir Hussain, Maria Elizabeth Vincent, Emil Tom John, et al.Bioethics|December 20, 2023
Therapeutic misunderstandings in modern researchSarah Heynemann, Wendy Lipworth, Sue-Anne McLachlan, et al.Internal Medicine Journal|February 23, 2023
When research becomes practice: the concept of the therapeutic misconception and challenges to consent in clinical trialsSarah Heynemann, Wendy Lipworth, Sue-Anne McLachlan, et al.Journal of Clinical Medicine|May 4, 2026
The Effect of Rate-Controlling Medication on the Performance and Outcome of Dobutamine Stress Echocardiography in the Assessment of Patients with Suspected Angina: A Retrospective Cohort StudyLaya Hariharan, Muhammad Zohaib Amjad, Emil Tom John, et al.Asia-Pacific Journal of Clinical Oncology|May 7, 2026
Navigating Evidence Standards: Stakeholder Perspectives on External Controls and Randomization in Cancer TrialsSarah E Heynemann, Wendy L Lipworth, Sue-Anne McLachlan, et al.ERJ Open Research|October 29, 2025
Development of a clinical core outcome set to evaluate lung cancer rehabilitationLara Edbrooke, Thomas W Davies, Catherine L Granger, et al.Future Oncology (London, England)|February 18, 2026
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancerRachel Woodford, Sally Lord, Tom John, et al.Pageof 3